Payden & Rygel’s Morgan Stanley MS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $33.7M | Sell |
161,100
-400
| -0.2% | -$79.2K | 2.58% | 8 |
|
|
2026
Q1 | $26.6M | Sell |
161,500
-14,400
| -8% | -$2.49M | 2.05% | 8 |
|
|
2025
Q4 | $31.2M | Sell |
175,900
-14,600
| -8% | -$2.44M | 2.16% | 8 |
|
|
2025
Q3 | $30.3M | Sell |
190,500
-200
| -0.1% | -$29.5K | 2.51% | 5 |
|
|
2025
Q2 | $26.9M | Buy |
190,700
+1,700
| +0.9% | +$209K | 2.22% | 6 |
|
|
2025
Q1 | $22.1M | Buy |
189,000
+5,500
| +3% | +$709K | 1.89% | 11 |
|
|
2024
Q4 | $23.1M | Buy |
183,500
+52,000
| +40% | +$6.4M | 1.99% | 9 |
|
|
2024
Q3 | $13.7M | Sell |
131,500
-61,300
| -32% | -$6.17M | 1.06% | 49 |
|
|
2024
Q2 | $18.7M | Sell |
192,800
-19,800
| -9% | -$1.88M | 1.51% | 29 |
|
|
2024
Q1 | $20M | Sell |
212,600
-128,100
| -38% | -$11.3M | 0.94% | 30 |
|
|
2023
Q4 | $31.8M | Buy |
340,700
+206,190
| +153% | +$16.5M | 2.21% | 4 |
|
|
2023
Q3 | $11M | Sell |
134,510
-3,100
| -2% | -$269K | 0.75% | 61 |
|
|
2023
Q2 | $11.8M | Sell |
137,610
-190,590
| -58% | -$16.3M | 0.83% | 61 |
|
|
2023
Q1 | $28.8M | Buy |
328,200
+55,300
| +20% | +$5.16M | 1.71% | 12 |
|
|
2022
Q4 | $23.2M | Buy |
272,900
+92,800
| +52% | +$7.91M | 1.24% | 38 |
|
|
2022
Q3 | $14.2M | Buy |
180,100
+8,300
| +5% | +$700K | 0.83% | 60 |
|
|
2022
Q2 | $13.1M | Sell |
171,800
-55,700
| -24% | -$4.56M | 0.79% | 61 |
|
|
2022
Q1 | $19.9M | Sell |
227,500
-215,100
| -49% | -$20.8M | 1% | 60 |
|
|
2021
Q4 | $43.4M | Sell |
442,600
-2,400
| -0.5% | -$239K | 2.01% | 8 |
|
|
2021
Q3 | $43.3M | Sell |
445,000
-112,100
| -20% | -$11.1M | 2.25% | 5 |
|
|
2021
Q2 | $51.1M | Sell |
557,100
-102,300
| -16% | -$8.77M | 2.44% | 2 |
|
|
2021
Q1 | $51.2M | Sell |
659,400
-12,100
| -2% | -$927K | 2.38% | 3 |
|
|
2020
Q4 | $46M | Sell |
671,500
-74,000
| -10% | -$4.25M | 2.36% | 3 |
|
|
2020
Q3 | $36M | Buy |
745,500
+48,800
| +7% | +$2.46M | 2.14% | 9 |
|
|
2020
Q2 | $33.7M | Buy |
696,700
+165,400
| +31% | +$6.95M | 2.14% | 8 |
|
|
2020
Q1 | $18.1M | Buy |
531,300
+154,831
| +41% | +$7.29M | 1.3% | 39 |
|
|
2019
Q4 | $19.2M | Sell |
376,469
-300,300
| -44% | -$14.2M | 1.2% | 40 |
|
|
2019
Q3 | $28.9M | Buy |
676,769
+6,069
| +0.9% | +$259K | 1.96% | 22 |
|
|
2019
Q2 | $29.4M | Buy |
670,700
+23,700
| +4% | +$1.06M | 2.01% | 17 |
|
|
2019
Q1 | $27.3M | Buy |
647,000
+54,400
| +9% | +$2.29M | 1.99% | 17 |
|
|
2018
Q4 | $23.5M | Buy |
+592,600
| New | +$25.9M | 1.9% | 17 |
|
Other funds holding MS
Payden & Rygel's MS Position: Q2 2026 in Review
Payden & Rygel reduced its Morgan Stanley (MS) stake by 0.25% in Q2 2026, selling an estimated $79.2K and leaving 161,100 shares worth $33.7M. The position accounts for 2.58% of the portfolio, ranked #8.
Payden & Rygel first reported a position in MS in Q4 2018 and has held it in 31 quarters since. The position peaked at $51.2M in Q1 2021. 2,724 funds tracked by Wall St. Rank hold MS as of Q2 2026.
- Payden & Rygel held 161,100 shares of Morgan Stanley worth $33.7M as of Q2 2026.
- Payden & Rygel sold 400 Morgan Stanley shares in Q2 2026, an estimated $79.2K.
- Morgan Stanley made up 2.58% of Payden & Rygel's portfolio in Q2 2026, its #8 holding.
- Payden & Rygel first reported a position in Morgan Stanley in Q4 2018 and has held it in 31 quarters since.
- Payden & Rygel's Morgan Stanley position peaked at $51.2M in Q1 2021.
- 2,724 funds tracked by Wall St. Rank held Morgan Stanley as of Q2 2026.
Based on Payden & Rygel's 13F filing for Q2 2026, filed 31 Jul 2026.